Clonal hemopoiesis was suspected in one case; still, the true germline P/LP TP53 variant detection rate was higher among breast cancer patients meeting genetic testing criteria (0.43%; 2/463) compared to the control database gnomAD (0.018–0.028%) [26]. Here, TP53 is linked to breast carcinoma.